{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:10:49Z","timestamp":1784765449201,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bbmt.2020.06.013","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T12:08:17Z","timestamp":1593000497000},"page":"1886-1893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Splenomegaly May Increase the Risk of Rejection in Low-Risk Matched Related Donor Transplant for Thalassemia, This Risk Can Be Partially Overcome by Additional Immunosuppression during Conditioning"],"prefix":"10.1016","volume":"26","author":[{"given":"Stalin","family":"Ramprakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Raghuram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Marwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajpreet","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Yaqub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Itrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Khan","family":"Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatheer","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Dhanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat Kumar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2020.06.013_bib0001","unstructured":"Prevalence of \u03b2-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. Available at: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3537975\/. Accessed June 24, 2017."},{"key":"10.1016\/j.bbmt.2020.06.013_bib0002","doi-asserted-by":"crossref","unstructured":"The inherited diseases of hemoglobin are an emerging global health burden.Blood J. Available at: http:\/\/www.bloodjournal.org\/content\/115\/22\/4331\/. Accessed June 24, 2017.","DOI":"10.1182\/blood-2010-01-251348"},{"issue":"5","key":"10.1016\/j.bbmt.2020.06.013_bib0003","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.bbmt.2020.06.013_bib0004","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","article-title":"Beta-thalassemia","volume":"353","author":"Rund","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bbmt.2020.06.013_bib0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.bmt.1705287","article-title":"Financial burden of national health insurance for treating patients with transfusion-dependent thalassemia in Taiwan","volume":"37","author":"Ho","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2020.06.013_bib0006","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/theoncologist.2014-0218","article-title":"Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico","volume":"20","author":"Jaime-P\u00e9rez","year":"2015","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.bbmt.2020.06.013_bib0007","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"21","key":"10.1016\/j.bbmt.2020.06.013_bib0008","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1089\/scd.2014.0123","article-title":"Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis","volume":"23","author":"Abdul Wahid","year":"2014","journal-title":"Stem Cells Dev"},{"issue":"6","key":"10.1016\/j.bbmt.2020.06.013_bib0009","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbmt.2009.02.009","article-title":"Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation","volume":"15","author":"Nakamae","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bbmt.2020.06.013_bib0010","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbmt.2009.08.006","article-title":"Incidence of viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients","volume":"15","author":"Satwani","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2020.06.013_bib0011","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/tid.12003","article-title":"Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens","volume":"15","author":"Kim","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.bbmt.2020.06.013_bib0012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.bmt.1703150","article-title":"Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation","volume":"28","author":"Martino","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bbmt.2020.06.013_bib0013","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","article-title":"Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia","volume":"9","author":"Iannone","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bbmt.2020.06.013_bib0014","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bbmt.2020.06.013_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ajh.24674","article-title":"Transplantation in thalassemia: revisiting the Pesaro risk factors 25 years later","volume":"92","author":"Angelucci","year":"2017","journal-title":"Am J Hematol"},{"issue":"22","key":"10.1016\/j.bbmt.2020.06.013_bib0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood.V114.22.659.659","article-title":"Risk stratification without a liver biopsy of patients with \u03b2 thalassemia major undergoing a matched related allogeneic bone marrow transplant","volume":"114","author":"Mathews","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.06.013_bib0017","series-title":"Handbook of family therapy","first-page":"742","article-title":"Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)","author":"Taher","year":"2014"},{"issue":"12","key":"10.1016\/j.bbmt.2020.06.013_bib0018","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00277-014-2154-5","article-title":"Response to hydroxycarbamide in pediatric \u03b2-thalassemia intermedia: 8 years\u2019 follow-up in Egypt","volume":"93","author":"El-Beshlawy","year":"2014","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.bbmt.2020.06.013_bib0019","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0889-8588(18)30430-1","article-title":"Bone marrow transplantation in thalassemia","volume":"5","author":"Lucarelli","year":"1991","journal-title":"Hematol Oncol Clin North Am"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2020.06.013_bib0020","first-page":"1944","article-title":"Impact of splenomegaly on outcomes of fully matched sibling bone marrow transplant among children with low risk thalassemia","volume":"130","author":"Ramprakash","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbmt.2020.06.013_bib0021","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0308-2261(21)00396-9","article-title":"Splenomegaly and hypersplenism","volume":"12","author":"Bowdler","year":"1983","journal-title":"Clin Haematol"},{"issue":"4","key":"10.1016\/j.bbmt.2020.06.013_bib0022","first-page":"247","article-title":"Delayed engraftment associated with splenomegaly in patients undergoing bone marrow transplantation for chronic myeloid leukaemia","volume":"5","author":"Helenglass","year":"1990","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2020.06.013_bib0023","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-3046.2008.00953.x","article-title":"Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation","volume":"13","author":"Mathews","year":"2009","journal-title":"Pediatr Transplant"},{"issue":"11","key":"10.1016\/j.bbmt.2020.06.013_bib0024","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2016.146811","article-title":"Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation","volume":"101","author":"Hart","year":"2016","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bbmt.2020.06.013_bib0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00277-018-3278-9","article-title":"Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"97","author":"Shimomura","year":"2018","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.bbmt.2020.06.013_bib0026","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/bmt.2017.199","article-title":"Rejection of paternal vs. maternal fully matched bone marrow grafts in children with thalassemia","volume":"52","author":"Ramprakash","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"10.1016\/j.bbmt.2020.06.013_bib0027","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/bloodadvances.2016004119","article-title":"ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia","volume":"1","author":"Faulkner","year":"2017","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.bbmt.2020.06.013_bib0028","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2003-09-3167","article-title":"Complications of beta-thalassemia major in North America","volume":"104","author":"Cunningham","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbmt.2020.06.013_bib0029","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/amiajnl-2013-002594","article-title":"A prospective international cooperative information technology platform built using open-source tools for improving the access to and safety of bone marrow transplantation in low- and middle-income countries","volume":"21","author":"Agarwal","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"6","key":"10.1016\/j.bbmt.2020.06.013_bib0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13312-010-0090-6","article-title":"Normal values of liver and spleen size by ultrasonography in Indian children","volume":"47","author":"Dhingra","year":"2010","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.bbmt.2020.06.013_bib0031","series-title":"Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)","author":"Maria Domenica","year":"2014"},{"issue":"6","key":"10.1016\/j.bbmt.2020.06.013_bib0032","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bmt.2012.249","article-title":"Effects of spleen status on early outcomes after hematopoietic cell transplantation","volume":"48","author":"Akpek","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bbmt.2020.06.013_bib0033","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/bmt.2009.188","article-title":"Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type","volume":"45","author":"Bacigalupo","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bbmt.2020.06.013_bib0034","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clml.2016.02.004","article-title":"Allogeneic transplantation for patients with advanced myelofibrosis: splenomegaly and high serum LDH are adverse risk factors for successful engraftment","volume":"16","author":"Gergis","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10.1016\/j.bbmt.2020.06.013_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.2010.08417.x","article-title":"Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC)","volume":"152","author":"Robin","year":"2011","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bbmt.2020.06.013_bib0036","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bbmt.2009.10.025","article-title":"Outcome of transplantation for myelofibrosis","volume":"16","author":"Ballen","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2020.06.013_bib0037","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","article-title":"Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia","volume":"103","author":"Elliott","year":"1998","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.bbmt.2020.06.013_bib0038","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbmt.2017.03.002","article-title":"The impact of splenectomy in myelofibrosis patients before allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Robin","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bbmt.2020.06.013_bib0039","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00277-016-2638-6","article-title":"Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study","volume":"95","author":"Gratwohl","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2020.06.013_bib0040","article-title":"Usefulness of low-dose splenic irradiation prior to reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in elderly patients with myelofibrosis","volume":"2016","author":"Matsubara","year":"2016","journal-title":"Case Rep Hematol"},{"issue":"4","key":"10.1016\/j.bbmt.2020.06.013_bib0041","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1620\/tjem.228.295","article-title":"Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly","volume":"228","author":"Ito","year":"2012","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"10.1016\/j.bbmt.2020.06.013_bib0042","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0609.1983.tb01451.x","article-title":"Influence of the spleen on the distribution of blood neutrophils: quantitative studies in the rat","volume":"30","author":"Rohrer","year":"1983","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.bbmt.2020.06.013_bib0043","article-title":"Laparoscopic splenectomy to salvage renal transplants from severe acute antibody-mediated rejection","volume":"2012","author":"Latzko","year":"2012","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.bbmt.2020.06.013_bib0044","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1749-8090-8-129","article-title":"Splenectomy increases the survival time of heart allograft via developing immune tolerance","volume":"8","author":"Zhu","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.bbmt.2020.06.013_bib0045","first-page":"261","article-title":"Prevention of hyperacute kidney rejection by early splenectomy: etiologic and therapeutic implications","volume":"23","author":"Thomas","year":"1972","journal-title":"Surg Forum"},{"issue":"1, pt 1","key":"10.1016\/j.bbmt.2020.06.013_bib0046","first-page":"419","article-title":"Splenectomy is a potent immunosuppressive modality for cardiac xenografting","volume":"25","author":"Carobbi","year":"1993","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.bbmt.2020.06.013_bib0047","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bmt.1703612","article-title":"Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation","volume":"30","author":"McCune","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2020.06.013_bib0048","first-page":"31","article-title":"Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics","volume":"16","author":"Slattery","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bbmt.2020.06.013_bib0049","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.bbmt.2017.05.030","article-title":"The case for high resolution extended 6-loci HLA typing for identifying related donors in the Indian subcontinent","volume":"23","author":"Agarwal","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120303682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120303682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:13:52Z","timestamp":1761059632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120303682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1083879120303682"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.06.013","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenomegaly May Increase the Risk of Rejection in Low-Risk Matched Related Donor Transplant for Thalassemia, This Risk Can Be Partially Overcome by Additional Immunosuppression during Conditioning","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}